sarcoidosis
Information
- Disease name
- sarcoidosis
- Disease ID
- DOID:11335
- Description
- "A hypersensitivity reaction type IV disease characterized by the growth of collections of inflammatory cells (granulomas) in multiple organs." [url:http\://en.wikipedia.org/wiki/Sarcoidosis, url:http\://ghr.nlm.nih.gov/glossary=sarcoidosis, url:http\://www.mayoclinic.org/diseases-conditions/sarcoidosis/basics/definition/con-20022569?_ga=1.188430891.2017809229.1415219956]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04388085 | Active, not recruiting | Validity, Reliability and Responsiveness of King's Sarcoidosis Questionnaire in a Danish Population | December 1, 2019 | April 30, 2024 | |
| NCT03621553 | Active, not recruiting | Phase 4 | Vitamin D Homeostasis in Sarcoidosis | July 1, 2010 | December 30, 2026 |
| NCT00005276 | Completed | A Case Controlled Etiologic Study of Sarcoidosis (ACCESS) | June 1995 | March 2003 | |
| NCT00005531 | Completed | Genetic Epidemiology of Sarcoidosis | December 1996 | November 2000 | |
| NCT00005542 | Completed | Sarcoid Genetic Analysis (SAGA) | May 1999 | April 2005 | |
| NCT00073437 | Completed | Phase 3 | A Study of Infliximab in Patients With Sarcoidosis | October 2003 | February 2005 |
| NCT00099424 | Completed | N/A | Exercise Training in Sarcoidosis (EXTRAS Study) | February 2004 | August 2005 |
| NCT00100204 | Completed | Salivary Proteins in Disease and Health | December 21, 2004 | April 19, 2011 | |
| NCT00217789 | Completed | Pathogen Specific Immunity in Patients With Sarcoidosis | July 2004 | June 2008 | |
| NCT00274352 | Completed | Phase 2 | A Study of Adalimumab to Treat Sarcoidosis of the Skin | September 2006 | February 2012 |
| NCT00305552 | Completed | Phase 3 | SARCOTHAL. Thalidomide in Skin Sarcoidosis | February 2005 | November 2007 |
| NCT00326534 | Completed | Rickettsial Genesis to Sarcoidosis in Denmark | September 2006 | March 2009 | |
| NCT00361387 | Completed | Phase 4 | Use of Focalin for Fatigue in Sarcoidosis | June 2006 | January 2008 |
| NCT00366509 | Completed | Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases | September 18, 2006 | October 27, 2016 | |
| NCT00369980 | Completed | Diagnostic Usefulness of Fluorine-18-α-Methyltyrosine PET in Combination With 18F-FDG in Sarcoidosis Patient | September 1998 | August 2005 | |
| NCT00373555 | Completed | N/A | Endobronchial Ultrasonography in the Diagnosis of Sarcoidosis | September 2006 | August 2008 |
| NCT00379275 | Completed | Eye and Immunogenetic Features of Sarcoidosis | September 18, 2006 | December 10, 2007 | |
| NCT00402623 | Completed | N/A | The Effect of Quercetin in Sarcoidosis | January 2006 | January 2006 |
| NCT00403650 | Completed | Phase 4 | Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension | November 2006 | September 2008 |
| NCT03926832 | Completed | N/A | Prevalence of Obstructive Sleep Apnea Syndrome in Sarcoidosis and Impact of CPAP Treatment on Associated Fatigue Status | April 27, 2019 | July 30, 2019 |
| NCT00001278 | Completed | Study of Eye Tissue for Sarcoidosis | May 1991 | April 2001 | |
| NCT00504621 | Completed | The Influence of Personality on Pulmonary Fibrosis and Sarcoidosis | August 2007 | January 2009 | |
| NCT00512967 | Completed | The Occurence of Inflammation and Oxidative Stress in Lung Diseases | September 2005 | June 2006 | |
| NCT00555347 | Completed | Phase 2/Phase 3 | Use of Armodafinil for Fatigue in Sarcoidosis | October 2007 | August 2011 |
| NCT00560989 | Completed | Identifying Shared Genetic Susceptibility Regions in Chronic Beryllium Disease and Sarcoidosis | March 2007 | March 2007 | |
| NCT00581607 | Completed | Phase 2/Phase 3 | Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension | April 2008 | December 2012 |
| NCT00626938 | Completed | Role of Proteomics in Diagnosing Sarcoidosis | March 2005 | March 2012 | |
| NCT00794274 | Completed | Phase 2/Phase 3 | The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis | November 2008 | December 2011 |
| NCT00851929 | Completed | Phase 2/Phase 3 | Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension | November 2008 | November 2011 |
| NCT00854672 | Completed | Muscle Strength and Exercise Capacity in Sarcoidosis Patients | January 2009 | September 2011 | |
| NCT00855205 | Completed | Phase 2 | Rituximab for Pulmonary Sarcoidosis | July 2009 | December 2012 |
| NCT00872612 | Completed | Phase 3 | Trial for the Diagnosis of Sarcoidosis | March 2009 | May 2012 |
| NCT00888212 | Completed | N/A | Minimally Invasive Techniques Or Surgery In the Diagnosis of Sarcoidosis | June 2008 | June 2009 |
| NCT00915330 | Completed | N/A | Rapid On-site Cytopathologic Evaluation in the Diagnosis of Hilar/Mediastinal Adenopathy | May 2009 | February 2010 |
| NCT00955279 | Completed | Phase 2 | A Study to Evaluate the Safety and Effectiveness of Ustekinumab or Golimumab Administered Subcutaneously (SC) in Patients With Sarcoidosis | November 2009 | August 2012 |
| NCT00958087 | Completed | Cardiac Sarcoidosis and FDG-PET | March 2004 | July 2010 | |
| NCT01074554 | Completed | Phase 1/Phase 2 | Trial of Antimycobacterial Therapy in Sarcoidosis | February 2010 | February 2011 |
| NCT01139710 | Completed | Sarcoidosis-associated Pulmonary Hypertension | October 2010 | June 2011 | |
| NCT01245036 | Completed | N/A | Efficacy of Antituberculous Therapy in Management of Sarcoidosis | January 2009 | March 2013 |
| NCT01361139 | Completed | Diagnosis of Cardio-Pulmonary Pathology Using Transthoracic Parametric Doppler (TPD) | August 2011 | November 2014 | |
| NCT01615484 | Completed | N/A | Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability | September 2013 | January 2017 |
| NCT01648933 | Completed | N/A | Perfusion Analysis Using Rubidium in Cardiac Sarcoidosis | July 2012 | February 2017 |
| NCT01658280 | Completed | Phase 4 | Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration for the Diagnosis of Hilar/Mediastinal Lymphadenopathies | August 2012 | July 2015 |
| NCT01687517 | Completed | Phase 3 | Efficacy and Safety of Influenza Vaccine During Sarcoidosis | October 2012 | October 2014 |
| NCT01729169 | Completed | Cardiac Sarcoidosis: FDG PET vs. Ga-DOTANOC PET | June 2012 | January 2015 | |
| NCT01831739 | Completed | Genomic Research in Sarcoidosis | May 2013 | September 2015 | |
| NCT01857401 | Completed | Development of a Novel Human In Vitro Sarcoidosis Model | December 19, 2012 | February 2, 2017 | |
| NCT01908868 | Completed | N/A | A Trial of EBUS-TBNA Versus Conventional TBNA in Diagnosis of Sarcoidosis | November 2011 | December 2012 |
| NCT01955824 | Completed | Phase 2/Phase 3 | A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy | May 2014 | November 2014 |
| NCT02036970 | Completed | Phase 2 | Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT | May 31, 2014 | May 16, 2018 |
| NCT02115854 | Completed | Labial Biopsy in Patients With Tuberculosis Disease | December 2010 | ||
| NCT02243995 | Completed | N/A | Physical Training in Sarcoidosis Patients | January 2013 | May 2014 |
| NCT02246023 | Completed | Phase 4 | Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy | January 2015 | February 2016 |
| NCT02265874 | Completed | Phase 1/Phase 2 | Nicotine Treatment for Pulmonary Sarcoidosis: A Clinical Trial Pilot Study | January 12, 2015 | November 1, 2021 |
| NCT02270333 | Completed | N/A | Inspiratory Muscle Training in Sarcoidosis | April 2012 | April 2014 |
| NCT02405897 | Completed | N/A | A Study to Evaluate the Efficacy and Safety of Fenestrated Cup Forceps Versus Fenestrated Alligator Forceps for Performing Transbronchial Lung Biopsy in Patients With Sarcoidosis | April 2015 | December 2015 |
| NCT02459431 | Completed | N/A | RCT Comparing 21 and 22 G Needle in the Diagnosis of Sarcoidosis by EBUS TBNA | December 2013 | November 2015 |
| NCT02520323 | Completed | The Lung Microbiome in Sarcoidosis | June 2015 | June 2017 | |
| NCT02546388 | Completed | N/A | Somatostatin Receptor Imaging in Patients With Suspected Cardiac Sarcoidosis | October 2015 | August 2018 |
| NCT02592837 | Completed | N/A | EBUS-TBNA vs Flex 19G EBUS-TBNA | May 2016 | December 14, 2017 |
| NCT02689050 | Completed | Optical Biopsy for Thoracic Lymph Nodes. | January 13, 2016 | March 22, 2017 | |
| NCT02735161 | Completed | N/A | Fatigue and Exercise Training in Patients With Sarcoidosis | April 2016 | May 2017 |
| NCT02863406 | Completed | N/A | Comparison of Characteristics of Bronchoalveolar Lavage Dusting and of Specific Questionnary Data in Healthy Volunteers and Patients Suffering From Sarcoidosis | February 2014 | July 2015 |
| NCT02875756 | Completed | Phase 2/Phase 3 | Effect of the Number of Needle Revolutions Inside the Node on the Diagnostic Yield of EBUS-TBNA in Sarcoidosis | August 2016 | December 2017 |
| NCT03048097 | Completed | Early Phase 1 | Optimizing Acquisition Parameters and Interpretive Methods of FDG-PET/CT With Rb-82 | February 1, 2017 | July 2, 2018 |
| NCT03108547 | Completed | Hair Cortisol and Testosterone Levels in Patients With Sarcoidosis | June 13, 2014 | January 5, 2015 | |
| NCT03176745 | Completed | Number of Multiple Breath Washout Tests in Adults With Pulmonary Disease and Healthy Controls | July 1, 2015 | January 15, 2017 | |
| NCT03259282 | Completed | Gammaglobulins Level is Predictive Factor of Evolution in Sarcoidosis | March 7, 2017 | March 22, 2017 | |
| NCT03265405 | Completed | Phase 4 | Efficacy and Safety of Two Glucocorticoid Regimens in the Treatment of Sarcoidosis | April 1, 2017 | October 31, 2022 |
| NCT03336736 | Completed | The Role of Physical Activity and Diet Within Pulmonary Sarcoidosis | November 7, 2017 | June 15, 2018 | |
| NCT03356756 | Completed | PET MRI Study in Patients With Cardiac Sarcoidosis | June 27, 2016 | February 23, 2024 | |
| NCT03561025 | Completed | N/A | Diagnostic Potential of PET/MRI in Cardiac Sarcoidosis | October 1, 2018 | October 1, 2020 |
| NCT03656003 | Completed | N/A | A Study Evaluating the Diagnostic Yield and Safety of the ProCore vs Conventional EBUS-TBNA Needle in Subjects With Suspected Sarcoidosis | August 1, 2018 | July 31, 2019 |
| NCT03793439 | Completed | Phase 1 | Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis | May 15, 2019 | June 24, 2021 |
| NCT03825224 | Completed | Evaluation of MyoStrain™ in Clinical Practice | April 15, 2019 | November 15, 2019 | |
| NCT03844698 | Completed | Association Between Cancer and Sarcoidosis | July 4, 2019 | September 16, 2021 | |
| NCT00000596 | Completed | Phase 2 | Diffuse Fibrotic Lung Disease | June 1978 | January 1983 |
| NCT04008069 | Completed | Phase 2 | Sarilumab in Patients With Glucocorticoid-Dependent Sarcoidosis | September 3, 2019 | September 9, 2022 |
| NCT04156789 | Completed | Obstructive Sleep Apnoea in Sarcoidosis | October 28, 2019 | October 31, 2021 | |
| NCT04178239 | Completed | Chronic Fatigue in Sarcoidosis | March 10, 2017 | February 2, 2018 | |
| NCT04388566 | Completed | Development of the Danish Prospective Sarcoidosis Registry and Baseline Characteristics of a Danish Sarcoidosis Cohort | December 1, 2019 | February 28, 2022 | |
| NCT04462068 | Completed | ACE and HLA Genotypes Predict Severity and Disease Progression in Danish Sarcoid Patients | December 1, 2019 | November 30, 2023 | |
| NCT04475653 | Completed | N/A | Benefit of Wearing an Activity Tracker in Sarcoidosis | July 8, 2016 | December 18, 2017 |
| NCT04481074 | Completed | N/A | Inspiratory Muscle Training in Patients With Interstitial Lung Disease | July 30, 2020 | April 30, 2021 |
| NCT04735302 | Completed | Radiographic Characteristics of Mediastinal and Hilar Lymph Nodes in Sarcoidosis | February 11, 2019 | January 22, 2021 | |
| NCT04743583 | Completed | Prevalence and Malignant Involvement of Calcified Intrathoracic Lymph Nodes in Patients Undergoing Endosonography | March 20, 2021 | December 31, 2022 | |
| NCT04743596 | Completed | High-definition Videobronchoscopy in Sarcoidosis | March 17, 2021 | September 30, 2022 | |
| NCT04770948 | Completed | N/A | An RCT of 19G EBUS-TBNA Needle in Suspected Sarcoidosis | March 1, 2021 | September 30, 2023 |
| NCT05089565 | Completed | Immune Response to SARS-CoV-2/COVID-19 Vaccination in Sarcoidosis | December 1, 2021 | December 31, 2022 | |
| NCT05181930 | Completed | Nuclear Magnetic Resonance Spectroscopic Analysis of Urinary Metabolome in Sarcoidosis (RMN-SARCURINES) | January 30, 2018 | June 1, 2021 | |
| NCT05230693 | Completed | N/A | SPARC Smartphone Application for the Management of Sarcoidosis-Associated Fatigue | February 23, 2022 | July 25, 2023 |
| NCT06043882 | Completed | Number of Participants Diagnosed With Sarcoidosis by Bronchoscopic Transbronchial Needle Aspiration After COVID- 2019 . | November 1, 2022 | May 30, 2023 | |
| NCT06396910 | Completed | TB and Sarcoidosis Granuloma | September 1, 2021 | July 1, 2023 | |
| NCT04896138 | Enrolling by invitation | University of Virginia Natural History Study | August 28, 2018 | August 31, 2035 | |
| NCT05458492 | Not yet recruiting | Phase 2 | Sirolimus in Cutaneous Sarcoidosis | July 2022 | May 2027 |
| NCT05110950 | Not yet recruiting | N/A | Endobronchial Ultrasound Needle Aspiration With and Without Suction | June 1, 2022 | June 26, 2024 |
| NCT06347939 | Recruiting | Mediastinal EBUS Cryobiopsy Study In Sweden | April 1, 2024 | December 31, 2028 | |
| NCT01610843 | Recruiting | Worldwide Sarcoidosis Research Study | December 2011 | February 23, 2025 | |
| NCT05438095 | Recruiting | Medication Adherence in Patients With Sarcoidosis | May 11, 2022 | August 31, 2025 | |
| NCT00470327 | Recruiting | A Study of the Natural Progression of Interstitial Lung Disease (ILD) | September 2005 | December 2025 | |
| NCT05421975 | Recruiting | Evaluating Airway Sarcoidosis Pathology With MRI | June 28, 2021 | February 1, 2024 | |
| NCT05392881 | Recruiting | Interstitial Lung Disease Research Unit Biobank | August 9, 2021 | March 1, 2032 | |
| NCT06238037 | Recruiting | Bone Mineral Density in Patients With Sarcoidosis | December 1, 2019 | April 30, 2024 | |
| NCT03902223 | Recruiting | N/A | Routine Cardiac Screening in Sarcoidosis Patients | April 5, 2019 | April 2029 |
| NCT04637165 | Recruiting | Exploring the Immunology of Sarcoidosis | November 11, 2019 | December 31, 2023 | |
| NCT03049254 | Recruiting | Mayo AVC Registry and Biobank | February 9, 2018 | March 2025 | |
| NCT03901196 | Recruiting | Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy) | January 22, 2020 | January 22, 2025 | |
| NCT03573362 | Recruiting | N/A | Effect of Needle Size in Diagnostic Yield of EBUS-TBNA in Sarcoidosis and Lymphoma | January 1, 2019 | December 2025 |
| NCT05628454 | Recruiting | N/A | Comparison of Three Different Puncture Techniques in EBUS-TBNA | November 1, 2022 | November 1, 2024 |
| NCT05635032 | Recruiting | Fibrosing ILD Biomarkers That Rule Acceleration | March 1, 2021 | March 31, 2026 | |
| NCT06234384 | Recruiting | Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry) | July 2013 | July 2033 | |
| NCT05689879 | Recruiting | Phase 3 | Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in Sarcoidosis | March 23, 2023 | March 2027 |
| NCT05524077 | Recruiting | N/A | Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia | July 8, 2020 | June 30, 2026 |
| NCT03145922 | Recruiting | Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis | January 2016 | January 2026 | |
| NCT05696795 | Recruiting | Phase 2 | Janus Kinase Inhibition in Sarcoidosis | June 1, 2023 | March 1, 2025 |
| NCT05751447 | Recruiting | N/A | Sarcoidosis and Immune Cells in Lung, Lymph Nodes and Blood | October 1, 2019 | May 1, 2034 |
| NCT04751279 | Recruiting | Expression and Role of the JAK/STAT Pathway in Sarcoidosis Granuloma Cells | March 9, 2021 | January 2, 2024 | |
| NCT05171478 | Recruiting | Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens | December 9, 2021 | December 8, 2024 | |
| NCT04758650 | Recruiting | Phase 2 | Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis | January 26, 2021 | January 26, 2025 |
| NCT02523092 | Recruiting | Phase 4 | Use of CXCL9 as a Biomarker of Acthar Efficacy | November 3, 2022 | December 2026 |
| NCT01745237 | Recruiting | Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis | September 2002 | June 2032 | |
| NCT05916638 | Recruiting | MoMa Signature During Granulomatosis | January 15, 2024 | October 2025 | |
| NCT03814317 | Recruiting | Phase 2 | Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension | January 30, 2020 | July 29, 2025 |
| NCT03858777 | Recruiting | N/A | Cell Free DNA in Cardiac Sarcoidosis | May 1, 2019 | June 30, 2026 |
| NCT04402086 | Recruiting | Rheumatology Patient Registry and Biorepository | August 4, 2020 | June 1, 2030 | |
| NCT03593759 | Recruiting | Phase 3 | Cardiac Sarcoidosis Randomized Trial | January 15, 2019 | December 2025 |
| NCT02168036 | Terminated | Study of Biologic Materials From the Mediastinal Lymph Nodes From Patients With Lung Disease. | August 16, 2011 | February 16, 2017 | |
| NCT00739960 | Terminated | Phase 2 | Safety Study of Abatacept to Treat Refractory Sarcoidosis | August 2008 | December 2008 |
| NCT00747461 | Terminated | Phase 4 | Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD") | October 2008 | March 2011 |
| NCT00837668 | Terminated | Stromal Gene Expression During Pulmonary Sarcoidosis | April 2005 | February 2012 | |
| NCT00926627 | Terminated | Phase 2 | Safety and Efficacy Study of Bosentan in Progressive Pulmonary Sarcoidosis | April 2009 | March 2010 |
| NCT01241942 | Terminated | N/A | Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability | December 2010 | March 2013 |
| NCT00311246 | Terminated | Phase 2 | Trial of Adalimumab in Progressive Sarcoidosis | April 2006 | September 2008 |
| NCT02134717 | Terminated | N/A | Impact of Chemokine Receptor 5 (CCR5) Inhibition on Sarcoidosis Immunophenotypes | January 2014 | May 2015 |
| NCT00282438 | Terminated | Phase 1/Phase 2 | Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis | December 2003 | August 2015 |
| NCT02472808 | Unknown status | N/A | A Trial to Compare Two Methods of Obtaining Tissue for Diagnosis of Sarcoidosis Namely the Conventional Method or the Ultrasound Guided Method | June 2015 | January 2016 |
| NCT02497079 | Unknown status | N/A | Diagnostic Accuracy of Polymerase Chain Reaction for Mycobacterium Tuberculosis Using EBUS-TBNA Samples | July 2015 | December 2018 |
| NCT02827734 | Unknown status | Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD) | October 2015 | December 2020 | |
| NCT02807025 | Unknown status | Nasal, Tracheal and Bronchial Mucosal Lining Fluid(MLF) Sampling From Patients With Respiratory Diseases | September 2015 | December 31, 2017 | |
| NCT02540694 | Unknown status | N/A | EBUS vs EUS-B for Diagnosing Sarcoidosis | May 2015 | June 2018 |
| NCT01836822 | Unknown status | N/A | Bronchoscopic Sampling Techniques in Sarcoidosis | March 2013 | May 2014 |
| NCT02643732 | Unknown status | N/A | Fatigue in Sarcoidosis - Treatment With Methylphenidate | November 2016 | July 2018 |
| NCT01467791 | Unknown status | Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH) | November 2011 | January 2018 | |
| NCT03769987 | Unknown status | Registry for Advanced Sarcodiosis | January 1, 2017 | June 30, 2020 | |
| NCT03528070 | Unknown status | Early Phase 1 | A Clinical Study of Tranilast in the Treatment of Sarcoidosis | May 2018 | December 2020 |
| NCT00932854 | Unknown status | N/A | A Clinical tRial of Endobronchial Ultrasound for the Diagnosis of MEDiastinal lymphadenopathY (REMEDY) | July 2009 | October 2011 |
| NCT01920919 | Unknown status | Phase 3 | Low-dose Dexamethasone in Newly Diagnosed Pulmonary Sarcoidosis | June 2013 | |
| NCT01809145 | Unknown status | N/A | Testing Hypersensitivity to Metals in Sarcoidosis Patients by Applying the MELISA Test. | March 2013 | December 2013 |
| NCT02989480 | Unknown status | PET-detected Myocardial Inflammation is a Characteristic of Cardiac Sarcoid But Not of ARVC | August 2015 | July 2019 | |
| NCT01830959 | Unknown status | Phase 4 | Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS) | April 2013 | October 2016 |
| NCT02625558 | Unknown status | Phase 4 | Riociguat for Sarcoidosis Associated Pulmonary Hypertension | April 2015 | October 2018 |
| NCT02155803 | Unknown status | Phase 2/Phase 3 | ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study | February 2015 | November 2015 |
| NCT02627209 | Unknown status | N/A | The Serum Angiotensin Converting Enzyme and Lysozyme Levels in Patients Non-infectious and Infectious Uveitis | June 2014 | January 2017 |
| NCT02188017 | Unknown status | Phase 4 | Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS) | June 2014 | September 2017 |
| NCT03312712 | Unknown status | Validation of the Analysis Methodology Behind the Use of Quantitative 18F-FDG PET/CT to Assess Lung Inflammation | January 23, 2018 | January 2022 | |
| NCT02916459 | Unknown status | N/A | EBUS-TBNA vs Flex 19G EBUS-TBNA | October 2016 | October 2018 |
| NCT04530461 | Unknown status | Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases | June 1, 2020 | January 31, 2021 | |
| NCT04508361 | Unknown status | Test-retest Reliability for Fatigue Assessment Scale, Short Form 6 Dimension and King's Sarcoidosis Questionnaire | April 19, 2019 | November 1, 2020 | |
| NCT04342403 | Unknown status | Patient Reported Outcome Instruments in Sarcoidosis | April 1, 2017 | December 1, 2020 | |
| NCT02348905 | Unknown status | Phase 2/Phase 3 | ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial | March 2015 | January 2016 |
| NCT02356445 | Unknown status | Use of Immunosuppressive Therapy for Sarcoidosis | November 2014 | December 2018 | |
| NCT02361281 | Unknown status | Validation of a Non-invasive Diagnostic Method for Sarcoidosis Using Exhaled Breath | December 2014 | July 2015 | |
| NCT02626897 | Unknown status | N/A | A Comparison of Accelerometers for Measuring Daily Activity in Sarcoid | January 2016 | May 2016 |
| NCT02829853 | Unknown status | Clinical and Genetic Study of Familial Sarcoidosis (SARCFAM) | January 2008 | September 2016 | |
| NCT01467635 | Withdrawn | N/A | EBUS-TBNA Versus EBUS-TBNB | May 2014 | July 2016 |
| NCT01210677 | Withdrawn | Phase 4 | Cardiac Sarcoidosis Response To Steroids Trial | April 2014 | December 2016 |
| NCT03805633 | Withdrawn | A Suspected Association Between Sarcoidosis and Development of Diabetes Mellitus | February 2, 2018 | January 31, 2020 | |
| NCT00785239 | Withdrawn | CryoSpray Ablation(tm)Thoracic Patient Registry | April 2009 | April 2009 | |
| NCT00731757 | Withdrawn | Phase 2 | Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis | May 2009 | December 2010 |
| NCT00690911 | Withdrawn | Phase 2 | Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis | ||
| NCT02920710 | Withdrawn | Phase 4 | ACTHAR Therapy for Central Nervous System Sarcoidosis | February 1, 2019 | November 2, 2020 |
| NCT02192489 | Withdrawn | Phase 2 | A Phase 2 Study With CC-220 in Skin Sarcoidosis | November 1, 2014 | June 30, 2017 |
| NCT04494334 | Withdrawn | Development of Airway Absorption Sampling Methods | January 1, 2022 | January 1, 2022 |
- Disase is a (Disease Ontology)
- DOID:2916
- Cross Reference ID (Disease Ontology)
- GARD:7607
- Cross Reference ID (Disease Ontology)
- ICD10CM:D86
- Cross Reference ID (Disease Ontology)
- ICD9CM:135
- Cross Reference ID (Disease Ontology)
- MESH:D012507
- Cross Reference ID (Disease Ontology)
- NCI:C34995
- Cross Reference ID (Disease Ontology)
- ORDO:797
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:154425004
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0036202
- Exact Synonym (Disease Ontology)
- Boeck sarcoid
- Exact Synonym (Disease Ontology)
- lymphogranulomatosis
- OrphaNumber from OrphaNet (Orphanet)
- 797
- ICD10 preferred id (Insert disease from ICD10)
- D0003338
- ICD10 class code (Insert disease from ICD10)
- D86
- MeSH unique ID (MeSH (Medical Subject Headings))
- D012507